Neither gemcitabine treatment nor tumor resection significantly influenced alveolar macrophages, dendritic cells (DCs), NK cells, B cells, CD4+ T cells, or CD8+ T cells in the lungs (Additional file 11: Figure S10), which is consistent with previous reports that gemcitabine preferentially targets certain myeloid cell populations. The gene discussed is CD4; the disease is neoplasm.